Burrows Scott L
CIK 0001853327
Chief Financial Officer
Filings
17
Latest Jun 3, 2026
Issuers covered
2
Showing
17 of 17
Page 1
Track record
14 of 17 open-market trades scored (82% price coverage) - 3 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 14 | 36% | -5.2% | -8.4% | +32.6% | -42.0% |
| 90 days | 11 | 36% | -8.4% | -19.3% | +52.5% | -74.1% |
| 180 days | 9 | 56% | -7.5% | +32.6% | +50.4% | -155.5% |
| 365 days | 8 | 100% | +23.0% | +25.3% | +36.8% | +4.6% |
Issuers
Companies where Burrows Scott L has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| SYRE | Spyre Therapeutics, Inc. | 11 | Jun 3, 2026 |
| ARQT | Arcutis Biotherapeutics, Inc. | 6 | Mar 8, 2023 |
All filings
17 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|